Pharmaceutical News Headlines for May 24 2012 ( Thursday )


• Rival Big Pharmas Strike $285 Million Antibiotic Deal More...

• Takeda Pharmaceutical Co. Ltd. (TKDG.DE)'s MAA Filing Triggers a $10 Million Milestone Payment to Furiex Pharmaceuticals, Inc. (FURX) More...

• Genmab A/S (GEN.CO) Release: Milestone Triggered in Connection With Filing of New Drug Application in Japan for Arzerra More...

• Medochemie Ltd Rapidly Deploys Cegedim Relationship Management'sAward Winning*, Cloud-Based Mobile Intelligence and World Leading OneKey™ Database to Drive Growth in Key Markets More...

• After Successful IPO, Verastem, Inc. (VSTM) Tries to Deliver on Promise More...

• GlaxoSmithKline (GSK) Avoids Market for Lemons by Buying Collaborators More...

• Germanys' Reimser is a Takeover Target More...

• Leader in Antibacterial Phage Technology Micreos Secures Growth Capital More...

• Transgenomic, Inc. (TBIO) Acquires Clinical Sample Biorepository from Gene Logic Inc. (GLGC) More...

• AspenBio Pharma, Inc. Appoints Diagnostics Industry Veteran Don Hurd as Senior Vice President and Chief Commercial Officer More...

• BiOxyDyn Limited Appoints Financial Advisors More...

• Prima Biomed (PRR.AX) Announces Changes to the Board and Senior Management More...

• Vertex Pharmaceuticals (MA) (VRTX) Appoints David Altshuler, M.D., Ph.D., to its Board of Directors More...

• Teva Pharmaceutical Industries Limited (TEVA) Provides Updated 2012 Non-GAAP Financial Outlook; Updated 2012 Non-GAAP Diluted EPS of $5.30 to $5.40 More...

• Shanghai Pharmaceutical Co., Ltd. Faces Media Charges of Accounting Fraud More...

• Auxilium Pharmaceuticals (AUXL) and FCB I LLC File Lawsuit Against Watson Laboratories, Inc. (WPI) for Infringement of Testim® Patents More...

• FDA Panel Rejects New Use for Johnson & Johnson (JNJ)'s Xarelto More...

• Gilead Sciences, Inc. (GILD) European Marketing Application for Boosting Agent Cobicistat More...

• XenoPort, Inc. (XNPT) Submits Investigational New Drug Application for XP23829 as a Potential Treatment of RRMS More...

• RetroSense Therapeutics Completes pre-IND Meeting for RST-001 More...

• Genmab A/S (GEN.CO) Release: Milestone Triggered in Connection With Filing of New Drug Application in Japan for Arzerra More...

• Breathe Deeply: Safety Concerns Over Boehringer Ingelheim Corporation's Spiriva More...

• MediciNova, Inc. Asthma Drug Fails Trial; Shares Crash -1.3201(48.00%) @ 10:08AM EDT More...

• Sanofi (France) (SAN.PA) Pins Hope on Cancer-starving Compound More...

• Cytokinetics, Inc. (CYTK) Announces Opening of Second Cohort in Phase IIb Clinical Trial of Intravenous Omecamtiv Mecarbil in Patients With Acute Heart Failure More...

• Genta Incorporated (GETA.OB) Announces Results of Tesetaxel Confirmatory Trial in Patients With Advanced Gastric Cancer More...

• Celldex Therapeutics, Inc. (CLDX)'s CDX-011 Demonstrates High Response Rates in Patients with Metastatic Breast Cancer Expressing Elevated Levels of GPNMB and in Triple Negative Disease More...

• Fever During Pregnancy More Than Doubles the Risk of Autism or Developmental Delay, University of California, Davis (UCD) Study More...

• Children's Body Fat Linked to Vitamin D Insufficiency in Mothers, University of Southampton Study More...

• Resilient People More Satisfied With Life, Universitat Autonoma de Barcelona Study More...

• Well-Connected Brains Make You Smarter in Older Age, University of Edinburgh Study More...

• Calcium Supplements May Be Bad for Your Heart, German Cancer Research Centre Study More...

• Patrys Limited (PATZF.PK) Granted Key Patent for Lead Product -- PAT-SM6 More...
Tags: , ,

About author

Make it happen !!

0 comments

Leave a Reply